Name

CMH21 Gene

Cardiomyopathy, familial hypertrophic, 21

IHPS2 Gene

Pyloric stenosis, infantile hypertrophic, 2

IHPS5 Gene

Pyloric stenosis, infantile hypertrophic, 5

IHPS4 Gene

Pyloric stenosis, infantile hypertrophic, 4

IHPS3 Gene

Pyloric stenosis, infantile hypertrophic, 3

CMR1A Gene

cardiomyopathy, restrictive 1A (autosomal dominant)

RCM2 Gene

cardiomyopathy, familial restrictive, 2

CMR2A Gene

cardiomyopathy, restrictive 2A (autosomal recessive)

CMD1K Gene

cardiomyopathy, dilated 1K (autosomal dominant)

CMD1H Gene

cardiomyopathy, dilated 1H (autosomal dominant)

CMD1F Gene

cardiomyopathy, dilated 1F (autosomal dominant)

CMD1B Gene

cardiomyopathy, dilated 1B (autosomal dominant)

CMD1Q Gene

cardiomyopathy, dilated 1Q (autosomal dominant)

CMYA5 Gene

cardiomyopathy associated 5

Predicted to enable identical protein binding activity and protein phosphatase inhibitor activity. Predicted to act upstream of or within negative regulation of calcineurin-NFAT signaling cascade and regulation of skeletal muscle adaptation. Located in cytosol; nuclear speck; and plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

CMR3A Gene

cardiomyopathy, restrictive 3A (X-linked)